These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 8769047)
1. Trends in the use of blood pressure lowering medications in Auckland, and associated costs, 1982-94. Trye P; Jackson R; Yee RL; Beaglehole R N Z Med J; 1996 Jul; 109(1026):270-2. PubMed ID: 8769047 [TBL] [Abstract][Full Text] [Related]
2. Trends and determinants of blood pressure in Auckland, New Zealand 1982-94. Trye P; Jackson R; Stewart A; Yee RL; Beaglehole R N Z Med J; 1996 May; 109(1022):179-81. PubMed ID: 8657382 [TBL] [Abstract][Full Text] [Related]
3. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
4. Trends in coronary heart disease risk factors in Auckland 1982-94. Jackson R; Yee RL; Priest P; Shaw L; Beaglehole R N Z Med J; 1995 Nov; 108(1011):451-4. PubMed ID: 8538961 [TBL] [Abstract][Full Text] [Related]
5. Trends in the prevalence and treatment of hypertension in Halifax County from 1985 to 1995. Wolf HK; Andreou P; Bata IR; Comeau DG; Gregor RD; Kephart G; MacLean DR; Sketris I CMAJ; 1999 Sep; 161(6):699-704. PubMed ID: 10513276 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive drug prescription trends at the primary health care centres in Bahrain. Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335 [TBL] [Abstract][Full Text] [Related]
7. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory? Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499 [TBL] [Abstract][Full Text] [Related]
8. Patterns in the drug treatment of hypertension in Auckland, 1982-7. Sinclair B; Jackson R; Beaglehole R N Z Med J; 1989 Sep; 102(876):491-3. PubMed ID: 2797571 [TBL] [Abstract][Full Text] [Related]
9. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure levels and the treatment of hypertension in Auckland, 1982. Jackson RT; Beaglehole R; Stewart AW N Z Med J; 1983 Oct; 96(741):751-4. PubMed ID: 6604888 [TBL] [Abstract][Full Text] [Related]
11. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy. Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550 [TBL] [Abstract][Full Text] [Related]
12. [Consumption of antihypertensive agents in obese patients: a cross-sectional study in a sample of 3,291 wage-earners in the Toulous region]. Lapeyre-Mestre M; Sulem P; Chastan E; Niezborala M; Briant D; Jansou P; Sanguignol F; Montastruc JL Arch Mal Coeur Vaiss; 2000 Aug; 93(8):925-9. PubMed ID: 10989731 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721 [TBL] [Abstract][Full Text] [Related]
14. Trends in antihypertensive medication costs in a cohort of Aucklanders 1982-87. Sinclair BL; Ashton T; Jackson R; Beaglehole R N Z Med J; 1989 Oct; 102(877):521-3. PubMed ID: 2797584 [TBL] [Abstract][Full Text] [Related]
15. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus]. Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043 [TBL] [Abstract][Full Text] [Related]
16. Variability in antihypertensive drug therapy in general practice: results from a random national survey. Kawachi I; Malcolm LA; Purdie G N Z Med J; 1989 Jun; 102(870):307-9. PubMed ID: 2567977 [TBL] [Abstract][Full Text] [Related]
17. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension. Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403 [TBL] [Abstract][Full Text] [Related]
18. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure. Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011 [TBL] [Abstract][Full Text] [Related]
19. Trends in cardiovascular risk factors in Auckland, 1982 to 1987. Jackson R; Beaglehole R; Yee RL; Small C; Scragg R N Z Med J; 1990 Aug; 103(895):363-5. PubMed ID: 2385396 [TBL] [Abstract][Full Text] [Related]
20. Blood pressure prevalences and levels for a multicultural population in Auckland, New Zealand: results from the Diabetes, Heart and Health Survey 2002/2003. Gentles D; Metcalf P; Dyall L; Scragg R; Black P; Schaaf D; Sundborn G; Jackson R N Z Med J; 2006 Nov; 119(1245):U2318. PubMed ID: 17146492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]